SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-18-031992
Filing Date
2018-02-05
Accepted
2018-02-05 14:16:03
Documents
1
Group Members
ANNE-MARI PASTEROMEGA FUND IV G.P. MANAGER, LTD.OMEGA FUND IV GP, L.P.OMEGA FUND IV, L.P.OTELLO STAMPACCHIARICHARD LIM

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d531621dsc13ga.htm SC 13G/A 144634
  Complete submission text file 0001193125-18-031992.txt   146672
Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Subject) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89113 | Film No.: 18573765
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMICORP LUXEMBOURG S.A. 11-13, BOULEVARD DE LA FOIRE GRAND DUCHY OF LUXEMBOURG N4 L-1528
Business Address C/O AMICORP LUXEMBOURG S.A. 11-13, BOULEVARD DE LA FOIRE GRAND DUCHY OF LUXEMBOURG N4 L-1528 352 2627 43 1
Global Life Bioventure IV S.a.r.l. (Filed by) CIK: 0001652769 (see all company filings)

IRS No.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13G/A